期刊文献+

MMP-9-PEX原核表达、纯化及其对结肠癌细胞侵袭能力的影响 被引量:1

Expression,Purification of the MMP-9-PEX in E.coil and Its Effect on Invasive Capacity of Colonic Cancer Cells
下载PDF
导出
摘要 用RT-PCR法扩增出基质金属蛋白酶-9(MMP-9)C末端血红素结合蛋白样结构域(PEX),克隆至表达载体pET32a中并转化至E.coilBL21(DE3),经IPTG诱导后在约为42kDa处发现有外源基因的表达,密度扫描显示表达蛋白含量占菌体总蛋白的50%左右。重组蛋白质pET32a/PEX主要以包涵体形式表达,其在上清液中的含量极微。含8mol/L尿素和10mmol/LDTT的裂解缓冲液溶解的包涵体采用金属整合层析有效分离出目标蛋白,纯化后pET32a/PEX蛋白质的纯度大于90%。在Transwell实验中发现复性纯化后的重组蛋白质pET32a/PEX能抑制结肠癌细胞的侵袭,且呈剂量依赖性。 Matrix metalloproteinase 9 hemopexin domain (PEX), which locates the C-terminal, was amplified by RT-PCR and was inserted into expression vector pET32a. The recombinant plasmid was induced by IPTG for 4 h and a 42 kDa recombinant protein was produced. Amount of the fusion protein pET32a/PEX expression was 50% of total bacterial protein, mostly in form of inclusion, few in form of supernatant. Inclusion was dissolved in 8 mol/L urea and 10 mmol/L DTT, carried out affinity purification under denaturing condition. The expressed 42 kDa fusion protein is confirmed by SDS-PAGE. The pET32a/PEX expression vector was successfully constructed and highly expressed in E.coli. The purified pET32a/PEX protein can inhibitor the invasion of the colonic cancer cell in Transwell experiments and show a dose-dependent manner.
出处 《细胞生物学杂志》 CSCD 2006年第5期717-720,共4页 Chinese Journal of Cell Biology
基金 重庆市科委攻关项目资助(No.7668)~~
关键词 基质金属蛋白酶-9 血红素结合蛋白样结构域 基因表达 细胞侵袭 matrix metalloproteinase-9 hemopexin domain gene expression cell invasion
  • 相关文献

参考文献11

  • 1Huppertz B et al.Cell Tissue Res,1998,291:133
  • 2Itoh Y et al.EMBO J,2001,20:4782
  • 3Roeb E et al.J Biol Chem,2002,277:50326
  • 4Das SK et al.Dev Genet,1997,21:44
  • 5Alexander CM et al.Development,1996,122:1723
  • 6Allan JA et al.Biochem J,1995,309:299
  • 7Overall CM et al.J Biol Chem,1999,274:4421
  • 8Brooks PC et al.Cell,1998,92:391
  • 9Pfeifer A et al.Proc Nati Acad Sci USA,2000,97:12227
  • 10Bello L et al.Cancer Res,2001,61:8730

同被引文献11

  • 1Qiu I., He D, Fan X, et al. The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas[J]. Pituitary,2011,14(3) :266 -275.
  • 2Gong J, Zhao Y, Abdel Fattah R, et al. Matrix metallopro- teinase-9,a potential biological marker in invasive pituitary adenomas[J]. Pituitary, 2008,11 ( 1 ) : 37-48.
  • 3Dufour A, Sampson NS, Li J, et al. Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinasc-9[J ]. Cancer Res, 2011, 71 ( 14 ) : 4977- 4988.
  • 4Remacle AC-, Golubkov VS, Shiryaev SA, et al. Novel MT1- MMP small molecule inhibitors based on insights into hemopexin domain function in tumor growth[J]. Cancer Res, 2012,72(9) :2339-2349.
  • 5Redondo-Mufioz J, Ugarte-Berzal E, Terol MJ, et al. Matrix metalloproteinase 9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain[J]. Cancer Cell, 2010,17(2) : 160-172.
  • 6Mantuano E, Inoue G, Li X, et al. The hemopexin domain of matrix metalloproteinase-9 activates cell signaling and promotes migration of schwann cells by hinding to low-density lipoprotein receptor related protein[J]. J Neurosci, 2008,28 (45):11571-11582.
  • 7Xiao Z, Liu Q, Mao F, et al. TNF-a-induced VEGF and MMP-9 expression promotes hemorrhagic transformation in pituitary adenomas[J]. Int J Mol Sci,2011,12(6) :4165-4179.
  • 8Langers AM, Verspaget HW, Hawinkels LJ, et al. MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients[J]. Br J Cancer, 2012,3(1) : 236-242.
  • 9Gonzcilez-Arriaga P, Pascual T, Garcia-Alvarez A, et al. Genetic polyrnorphisms in MMP 2,9 and 3 genes modify lungcancer risk and survival[J ]. BMC Cancer, 2012, 12 ( 1 ) : 121- 128.
  • 10Katunina AI, Gershtein ES, Ermilova VD, et al. Matrix metalloproteinases 2,7, and 9 in tumors and sera of patients with breast cancer[J]. Bull Exp Biol Med, 2011,151(3) : 359- 362.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部